The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
LRRK2 Therapeutic and Safety Initiative, 2017Genetic and Clinical Basis for Inflammatory Bowel Disease and Parkinson's Disease Comorbidity
Study Rationale:
Recent studies have shown that mutations in the LRRK2 gene, known to increase the risk of Parkinson’s disease (PD), are also associated with inflammatory bowel disease (IBD), a... -
LRRK2 Biology Consortium, 2017LRRK2 Activity and Dyskinesia
Promising Outcomes of Original Grant:
Leucine-rich repeat kinase 2 (LRRK2) is the greatest known genetic contributor to Parkinson's disease (PD). We previously studied the role of LRRK2 in the... -
Computational Science, 2017International Study of Parkinson's-related Changes in Brain Pathways Using Imaging Technique
Study Rationale:
Because Parkinson's disease (PD) affects people around the world regardless of their ethnicity or place of residence, research to find a cure for Parkinson's is truly an international... -
Research Grant, 2017T Cell-mediated Autoimmune Responses in Parkinson's Disease
Study Rationale
The protein alpha-synuclein, which is misprocessed in nearly every case of Parkinson's disease (PD), forms the Lewy bodies seen in PD patient brain. In our recent MJFF-funded study, our... -
Research Grant, 2017Using Immune Cells to Treat Parkinson's Disease
Study Rationale:
While significant strides have been made toward therapies that can prevent, slow or stop Parkinson's disease (PD) progression, no currently approved Parkinson's treatment can do this... -
Access to Data and Biospecimens, 2017An 8-protein panel for diagnosis of Parkinson’s Disease: Sample request for replication in PDBP and PPMI
Study Rationale:
We have previously found a panel of 8 proteins that can be measured in the blood that together distinguish people who have Parkinson’s Disease vs. people who do not. We are trying to...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.